Clinical Trials Browser

Phase 2 × Clear-cell metastatic renal cell carcinoma × tivozanib × Clear all

NCT07218692 2025-10-20

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Phase 2 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell